We are live on
!
Find out more
GC
Grimes & Company Portfolio holdings
AUM
$4.62B
1-Year Est. Return
29.71%
This Fund
S&P 500
This Quarter
Est. Return
-1.23%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$710M
AUM Growth
+$294M
(+71%)
Cap. Flow
+$320M
Cap. Flow
% of AUM
45.02%
Top 10 Holdings %
Top 10 Hldgs %
42.15%
Holding
214
New
43
Increased
64
Reduced
57
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$49.7M |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$48.3M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$40.9M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$38.7M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$33.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$9.29M |
| 2 |
Cognizant
CTSH
|
+$5.8M |
| 3 |
Western Union
WU
|
+$4.47M |
| 4 |
Advance Auto Parts
AAP
|
+$4.12M |
| 5 |
Conagra Brands
CAG
|
+$2.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.27% |
| 2 | Industrials | 9.49% |
| 3 | Financials | 6.29% |
| 4 | Consumer Discretionary | 6.11% |
| 5 | Healthcare | 4.69% |
Similar funds
DWM
ANTB
VCM
ACM
AG
KCM
SCM
ASC
Grimes & Company's Q2 2015 Portfolio in Review
As of Q2 2015, Grimes & Company held 214 positions worth $710M, up 71% from $416M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Grimes & Company deployed $320M of net new capital in Q2 2015, opening 43 new positions and adding to 64 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 1,628,740 shares worth $48.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 28% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $9.29M trimmed.
- Grimes & Company's largest Q2 2015 buy was iShares Core S&P Mid-Cap ETF: 1,628,740 shares worth $48.9M.
- Grimes & Company added most to Teradata in Q2 2015, an estimated $1.02M increase.
- Grimes & Company's biggest Q2 2015 reduction was Novo Nordisk, cutting an estimated $9.29M.
- Grimes & Company fully exited Advance Auto Parts in Q2 2015, selling an estimated $4.12M.
- Grimes & Company's ten largest holdings make up 42% of its $710M portfolio in Q2 2015.
- Grimes & Company opened 43 new positions and closed 24 in Q2 2015.
- Grimes & Company's portfolio value rose 71% quarter-over-quarter to $710M.
Based on Grimes & Company's 13F filing for Q2 2015, filed 11 Aug 2015.